Octreotide, 111 IN Uses, Dosage, Side Effects and more
Octreotide, 111 IN has been used in trials studying the diagnosis of Cushing's syndrome.
| Trade Name | Octreotide, 111 IN |
| Generic | Pentetreotide |
| Pentetreotide Other Names | Pentetreotida, Pentetreotide |
| Type | |
| Formula | C63H87N13O19S2 |
| Weight | Average: 1394.58 Monoisotopic: 1393.568259981 |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Russia |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Octreotide, 111 IN is a somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours.
Octreotide, 111 IN is also used to associated treatment for these conditions: Carcinoid Tumors, Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
